Search

Search Constraints

You searched for: Author/Creator Schneeweiss, Andreas

Search Results

1. Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial. Issue 16 (December 2015)

2. Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study. (1st February 2021)

3. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2020)

4. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?. (December 2016)

6. CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer. (2021)

7. CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer. (22nd April 2021)

8. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials. (July 2021)

9. Circulating microRNAs in plasma as early detection markers for breast cancer. Issue 7 (14th September 2012)

10. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Issue 8 (August 2021)